Title:
多発性硬化症を治療するためのクラドリビン投薬計画
Document Type and Number:
Japanese Patent JP5795456
Kind Code:
B2
Abstract:
The present invention is related to a Cladribine dosage regimen for use in the treatment of multiple sclerosis, especially relapsing-remitting multiple sclerosis or early secondary progressive multiple sclerosis, wherein the Cladribine is orally administered and wherein re-treatments are possible.
Inventors:
Derca, Giampiero
Arnie
Munafo, Allen
Lopez-Bresnahan, Maria
Arnie
Munafo, Allen
Lopez-Bresnahan, Maria
Application Number:
JP2007547486A
Publication Date:
October 14, 2015
Filing Date:
December 20, 2005
Export Citation:
Assignee:
Merck Serono Society Anonym
International Classes:
A61K31/7076; A61P25/00; C07H19/173
Other References:
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS,1995年43(5-6),pp.323-327
Medical Science Monitor,1998年,4(1),pp.4-8
Medical Science Monitor,1998年,4(1),pp.4-8
Attorney, Agent or Firm:
Atsushi Aoki
Takashi Ishida
Fukumoto product
Tetsuji Koga
Yoichi Watanabe
Ryotaro Takei
Takahide Sasaki
Takashi Ishida
Fukumoto product
Tetsuji Koga
Yoichi Watanabe
Ryotaro Takei
Takahide Sasaki